CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$4,670,919
+194.6%
283,086
+12.8%
0.00%
Q2 2023$1,585,423
+91.3%
250,858
+2.8%
0.00%
Q1 2023$828,567
-31.6%
244,055
+16.5%
0.00%
Q4 2022$1,210,933
-45.7%
209,504
-11.7%
0.00%
-100.0%
Q3 2022$2,230,000
-58.4%
237,217
-1.3%
0.00%
-50.0%
Q2 2022$5,362,000
-59.3%
240,316
+0.3%
0.00%
-50.0%
Q1 2022$13,167,000
-14.6%
239,485
+2.7%
0.00%
-20.0%
Q4 2021$15,413,000
-19.3%
233,204
+2.5%
0.01%
-16.7%
Q3 2021$19,097,000
-33.2%
227,498
+1.0%
0.01%
-40.0%
Q2 2021$28,592,000
+24.0%
225,252
+7.2%
0.01%
+25.0%
Q1 2021$23,057,000
-9.7%
210,179
+17.6%
0.01%
-20.0%
Q4 2020$25,527,000
+105.7%
178,797
+1.7%
0.01%
+66.7%
Q3 2020$12,409,000
+18.8%
175,838
+17.8%
0.01%
+20.0%
Q2 2020$10,446,000
+166.2%
149,266
+33.0%
0.01%
+150.0%
Q1 2020$3,924,000
-43.3%
112,229
+2.0%
0.00%
-50.0%
Q4 2019$6,918,000
+107.4%
110,051
+10.6%
0.00%
+100.0%
Q3 2019$3,335,000
+275.1%
99,487
+190.8%
0.00%
+100.0%
Q2 2019$889,000
+286.5%
34,209
+146.7%
0.00%
Q1 2019$230,000
+52.3%
13,8660.0%0.00%
Q4 2018$151,000
-56.6%
13,8660.0%0.00%
Q3 2018$348,000
+62.6%
13,866
+41.5%
0.00%
Q2 2018$214,0009,8000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 4,488,972$640,891,00035.51%
Antipodean Advisors LLC 656,000$93,657,00026.30%
KPS Global Asset Management UK Ltd 1,021,830$145,887,00021.39%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 302,700$43,216,00017.58%
Oakcliff Capital Partners, LP 269,895$38,533,00015.30%
Alua Capital Management LP 920,259$131,385,0009.19%
Covey Capital Advisors, LLC 47,736$6,815,0005.95%
EVR Research LP 50,000$7,139,0005.83%
683 Capital Management, LLC 659,997$94,228,0004.46%
Hidden Lake Asset Management LP 72,900$10,408,0004.08%
View complete list of CARDLYTICS INC shareholders